Navigation Links
Green Tea May Negate the Effects of a Common Cancer Therapy
Date:2/3/2009

WASHINGTON, Feb. 3 /PRNewswire-USNewswire/ -- Green tea products have become regarded as a valuable health supplement, as studies have shown evidence of its benefit against a variety of diseases, including cancer. However, a new study suggests that some components of green tea may counteract the anticancer effects of one cancer therapy, bortezomib (Velcade(R)), and may be contraindicated for patients taking this medicine to ensure its maximum therapeutic benefit. This study is being prepublished online today in Blood, the official journal of the American Society of Hematology.

Because of its increasing popularity and availability to the public in many formulations, green tea has been increasingly studied to understand its effect on cancer, heart disease, and other conditions. In animal studies, an antioxidant compound in green tea called the EGCG polyphenol (epigallocatechin gallate) has been shown to be a potent anticancer agent, with effects demonstrated against leukemia, as well as lung, prostate, colon, and breast cancer. Among other properties, EGCG binds to a common protein in tumors called GRP78 (which is responsible for preventing cell death) and inhibits its function, thereby assisting in the death of tumor cells.

"We know that cancer patients look to green tea extracts among other natural supplements to complement their therapeutic regimens. We wanted to better understand how the compounds in green tea interact with a cytotoxic chemical therapy and how that may affect patient outcomes," said Axel Schonthal, Ph.D., of the University of Southern California Keck School of Medicine and senior study author.

In this study, researchers evaluated whether the combination of green tea and bortezomib would improve outcomes against multiple myeloma, a blood cancer, and glioblastoma, a malignant brain tumor. Bortezomib, an anticancer therapy approved to treat multiple myeloma and mantle cell
'/>"/>

SOURCE American Society of Hematology
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Milkscreen Home Test for Alcohol in Breast Milk Begins Nationwide Sales at Walgreens
2. Recent U.S. Ambassador to Tanzania Mark Green Named Managing Director of Malaria No More Policy Center
3. Healthcare Sector Leaders Urge Obama, Congress to Invest in Alternative Energy and Green Jobs in Healthcare
4. DSM Joins the American Chemical Society Green Chemistry Institute(R)s Pharmaceutical Roundtable
5. Waking Up And Getting Ready: New Green Guide Advocates Simple Living and Earth-Centered Spirituality
6. CMS Data Services Reports Record Response to Data Media "GREEN" Repurchase Program
7. My1Stop.com Partners with Green Business Alliance to Help Customers Go Green
8. Chicago's First Eco-friendly, Green Luxury Dental Practice - ORA Dental Studio - is Finally Here
9. Greenland's National Management of Health Partners with AMD Global Telemedicine Inc. and AFHCAN to Install Telemedicine Encounter Management Systems (TEMS) Across Greenland
10. Greenway Medical Technologies EHR Solution, PrimeSuite, Wins Three Best in KLAS Awards
11. Be Green with B. Braun: Company Shares Expertise, Environmentally Responsible Products at ASHP 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... ... July 28, 2015 , ... Conducting Advanced Root ... to Improve the Quality of Investigations , **Presented by FDAnews and Learning Plus**, ... CAPAs have been the #1 reason for 483 observations since 1997! , The ...
(Date:7/27/2015)... NY (PRWEB) , ... July 28, 2015 , ... ... a 2015-2016 inductee into the NAPW VIP Woman of the Year Circle. She is ... and over 200 operating Local Chapters, NAPW is the nation’s leading networking organization exclusively ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... science of the little-known and incurable disease, facioscapulohumeral muscular dystrophy (FSHD), today announced ... of Neurology (AAN). The FSHD care guideline is published today. , This ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... North Central ... 2015. , The center invites all those prospective joint-replacement patients, along with their ... Thursday of each month, with Monday classes (Aug 6, Sept 8 [Tue due to ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... is a professional and in-depth research report. The report provides basic information ... market analysis etc. This report covers the global (US, Europe, Japan etc) ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 2Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 3Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 4Health News:NAPW Inducts Jane Simmons, Counseling Intern at Omar Bradley Middle School of the Northeast Independent School District , Into its VIP Woman of the Year Circle 2Health News:First-Ever FSHD Evidence-based Care Guideline Published by the American Academy of Neurology 2Health News:North Central Surgical Center Hospital to Hold Joint Wellness Classes 2Health News:Calcium Propionate Market Global Suppliers and Manufacture Analysis 2Health News:Calcium Propionate Market Global Suppliers and Manufacture Analysis 3
... Address FDA,s Next Big Challenge, Is the Food ... Devices to Physicians and the Public?, WASHINGTON, Nov. ... device that repairs damaged cells and treats cancer through,electromagnetic ... its apparent connection to patient injuries and death. However,on ...
... - The Westaim Corporation,announced today that it has reached ... in Canadian third party asset-backed commercial paper (ABCP) with,a ... $6.0 million.,Westaim retains the right to receive additional proceeds ... six months; in such event, Westaim,will receive 50 per ...
... (Nasdaq: FLEX ),today announced that it will report ... earnings conference call, hosted by Flextronics,s senior,management, will be ... results,of the Company for its third quarter ended December ... via the Internet and may be,accessed by logging on ...
... may be undertreated compared to white patients, research suggests , ... likely than white women to suffer severe pain linked to ... than 1,100 patients in 19 countries. , The women -- ... given a pain test called the Brief Pain Inventory repeatedly ...
... Kocot and Robert,Seidman Headline Agenda at FDA/CMS Summit ... has,progressed beyond a topic of industry insider buzz ... and private payers. Value isn,t a new,concept in ... for buying and,selling biopharmaceuticals? How is value calculated, ...
... Nov. 26 Pharmasset, Inc.,(Nasdaq: VRUS ) ... & Sales, responsible for coordinating the global product ... Higgins, who,has served as a consultant to Pharmasset ... Virology at Hoffmann-LaRoche, Inc. His areas,of expertise include ...
Cached Medicine News:Health News:Food and Drug Law Institute Sponsors Colloquium on Communicating Risk/Safety Drug Information 2Health News:Westaim reduces ABCP exposure 2Health News:Flextronics to Report Third Quarter Results 2Health News:Defining the Value of Medicine in an Evidence-Based Healthcare Marketplace 2Health News:Defining the Value of Medicine in an Evidence-Based Healthcare Marketplace 3Health News:Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales 2Health News:Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales 3
(Date:7/27/2015)... , July 20, 2015 Research ... addition of the "Key Pharma News Issue" ... This acquisition bolsters Gilead Sciences, burgeoning oncology pipeline ... will make further oncology deals in 2015, with ... of 2016. Key Pharma News ...
(Date:7/27/2015)... Belgium , July 27, 2015 /PRNewswire/ ... life sciences company focused on developing blood-based diagnostic tests ... conditions, today announced that it has engaged the services ... Specimen Solutions, Inc. (GSS), to support initial U.S. market ... Under the agreement, GSS will target ...
(Date:7/27/2015)... , July 27, 2015 Syneron ... ) , a global market leader in the aesthetic ... Korean Ministry of Food and Drug Safety (MFDS) regulatory ... clearance, the Company can fulfill PicoWay orders from its ... Korea anticipated later in the third quarter 2015. ...
Breaking Medicine Technology:Key Pharma News Issue - Gilead will make further oncology deals in 2015 2Key Pharma News Issue - Gilead will make further oncology deals in 2015 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 2VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 4VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 5VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 6VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 7Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 2Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 3Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 4
... Interventional Radiology Treatment Relieves Pain From Herniated Disks; ... but With Fewer Complications, Shorter Recovery TimeSAN DIEGO, ... treatment--that safely and effectively uses oxygen/ozone to relieve ... the United States in the next few years, ...
... Minimally Invasive "Lumpectomy" -- as Effective as Surgery -- ... Mapping Biopsy Changed Patients, Management 70 Percent of the ... -- a minimally invasive interventional radiology treatment for prostate ... diseased tumors and can be considered a first-line treatment ...
Cached Medicine Technology:Oh, My Aching Back: Give Me a Shot of Ozone 2Oh, My Aching Back: Give Me a Shot of Ozone 3Oh, My Aching Back: Give Me a Shot of Ozone 4Oh, My Aching Back: Give Me a Shot of Ozone 5Freezing Prostate Cancer Does a Man's Body Good 2Freezing Prostate Cancer Does a Man's Body Good 3Freezing Prostate Cancer Does a Man's Body Good 4Freezing Prostate Cancer Does a Man's Body Good 5Freezing Prostate Cancer Does a Man's Body Good 6Freezing Prostate Cancer Does a Man's Body Good 7
Inquire...
Glucose tubes contain an anti-coagulant and a stabiliser. The tubes are ideal for glucose and lactate determinations....
BD Vacutainer® Fluoride Tubes - Glass...
VACUETTE Trace Element tubes - Ridged (safety screw cap) are designed to test trace elements such as Cu, Zn, Pb, etc....
Medicine Products: